HP Inc. Appoints Karen Parkhill as CFO

HP Inc. has announced the appointment of Karen Parkhill as its new Chief Financial Officer, effective August 5, 2024. Parkhill brings with her 13 years of experience as a CFO for established publicly traded companies, most recently serving as the Executive Vice President and CFO for Medtronic plc.

During her tenure at Medtronic plc, Parkhill played a pivotal role in driving growth through innovation, a skill set that HP Inc. is eager to leverage as it advances its "future ready" strategy. Parkhill's extensive background in finance, including experience in investment banking at JP Morgan and as Vice Chairman and CFO at Comerica Incorporated, positions her well to contribute to HP's financial model and operational rigor.

In addition to her professional accomplishments, Parkhill also brings a wealth of experience in board leadership, currently chairing the risk committee at American Express. She is also involved in various organizations such as the International Women's Forum, Boys and Girls Club of America, Methodist Health System, and the executive board for Southern Methodist University Cox School of Business.

HP Inc. President and CEO Enrique Lores expressed enthusiasm about Parkhill's appointment, highlighting her unique position to drive growth and create value for stakeholders as the company continues its transformation.

This change in leadership comes at a significant time for HP Inc., as the company continues to undergo extraordinary transformation. Karen Parkhill's appointment is expected to play a crucial role in HP's pursuit of long-term sustainable growth.

HP Inc. (NYSE: HPQ) is a global technology leader operating in over 170 countries, providing innovative and sustainable devices, services, and subscriptions for personal computing, printing, 3D printing, hybrid work, and gaming. As a result of these announcements, the company's shares have moved -3.3% on the market, and are now trading at a price of $35.08. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.